Navigation Links
Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
Date:4/17/2013

NEW YORK, April 17, 2013 /PRNewswire/ -- Cactus Ventures, Inc. (OTCBB: CTVN; OTCBB: ATNM), (the "Company") announced today that following the change of the Company's name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc., the Company will change the trading symbol of its common stock on the OTC Bulletin Board to "ATNM." The new name and trading symbol are effective at the open of the market on April 18, 2013.

In a Schedule 14C filed January 29, 2013 with the Securities and Exchange Commission, the Company announced its new name and a change in the state of incorporation from the State of Nevada to the State of Delaware by merging the Company into Actinium Pharmaceuticals, Inc., a newly formed Delaware company.

About Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (OTCBB: ATNM) is a New York based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 isotopes in association with monoclonal antibodies.  The Company also develops other radiopharmaceuticals for select applications.

For more information:
Visit our web site
www.actiniumpharmaceuticals.com or contact:

Sergio Traversa , Interim Chief Executive Officer and Chief Financial Officer, Actinium Pharmaceuticals Inc.
Telephone:  (646) 459-4201
E-mail:  straversa@actiniumpharmaceuticals.com

Media: 

Dennis S. Dobson Jr.
Tel: (203) 258-0159
Email: dsdobson@optonline.com
www.dobsonmediagroup.com

Forward-Looking Statement for Actinium Pharmaceuticals, Inc.
This news release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential, or financial performance.  No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Actinium Pharmaceuticals undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. EntreMed Announces Changes to Board of Directors and CEO Appointment
2. Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness
3. Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
4. Medicare Recipients Will Suffer from Alarming New Changes by the CMS, Says MetroStar Home Health COO Isaac Newman
5. Hospira Announces Executive Changes
6. Pharmacy Technician Certification Board Announces Certification Program Changes
7. Power Wheelchairs Supplier MedSupplyShop.com Highlights Upcoming Changes to Medicare Competitive Bidding Program
8. Uroplasty Announces Executive Changes In US Sales Organization
9. HOLOGIC ANNOUNCES ORGANIZATIONAL CHANGES TO ITS DIAGNOSTICS SEGMENT; INTEGRATION OF GEN-PROBE PROCEEDING AHEAD OF SCHEDULE
10. AspenBio Pharma Changes Company Name to Venaxis, Inc.
11. PhRMA Statement on Proposed Changes to Medicaid in Louisiana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... Therapix Biosciences Ltd. (Nasdaq: TRPX), a ... development of cannabinoid-based drugs, today announced that the ... three upcoming scientific and investor conferences in June: ... ... Wednesday, June 7 ...
Breaking Medicine Technology:
(Date:6/23/2017)... DeSoto, Kan. (PRWEB) , ... June 23, 2017 , ... ... Kan. , The restaurant is located at 4210 SW 21st St. Topeka, Kan. ... Brandon Graham, owner of Graham Restaurant Group who owns three other locations in the ...
(Date:6/23/2017)... ... 2017 , ... 21 Middle East and South Asia Leaders Selected as Eisenhower ... business and civil society in 11 countries across the Middle East and South Asia ... transformative exchange of knowledge and ideas with the leading minds in their fields. ...
(Date:6/23/2017)... ... 23, 2017 , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) ... fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local ... Hansen in Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. ...
(Date:6/23/2017)... ... ... All-Star Insurance, a family managed agency that offers insurance management assistance and personal ... of a new charity drive to benefit women in the area diagnosed with breast ... estimated 252, 710 new cases of invasive or high risk breast cancer will be ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is proud to ... for 2017. Each year, research and information firm, Castle Connolly, releases their list of ... 2015, this marks the 3rd time that Dr. Canales has been recognized ...
Breaking Medicine News(10 mins):